Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Trader Loracle's ZEC Long Position Shows Unrealized Gain of Over $2.8 Million

Trader Loracle's ZEC Long Position Shows Unrealized Gain of Over $2.8 Million

BlockBeatsBlockBeats2026/06/08 03:50

BlockBeats News, June 8th, according to Onchain Lens monitoring, with ZEC rebounding, trader Loracle's ZEC 10x long position is currently sitting on a floating profit of over $2.8 million. However, their positions in HYPE, NEAR, WLD, TON, ASTER, and XMR are still significantly in the red.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage